Published in FEBS J on January 01, 2009
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol (2010) 4.37
The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation (2010) 1.54
NADPH oxidase is involved in post-ischemic brain inflammation. Neurobiol Dis (2011) 1.28
CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia. Ann Neurol (2012) 1.27
Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front Synaptic Neurosci (2010) 1.25
Drowning stars: reassessing the role of astrocytes in brain edema. Trends Neurosci (2014) 1.13
Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation (2010) 1.11
IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis (2013) 1.11
A role for spleen monocytes in post-ischemic brain inflammation and injury. J Neuroinflammation (2010) 1.10
Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol (2013) 1.09
Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS One (2013) 1.08
The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J Neuroinflammation (2013) 1.07
Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here. J Cereb Blood Flow Metab (2014) 1.07
Increased expression of the chemokines CXCL1 and MIP-1α by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J Neuroinflammation (2011) 1.06
Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol (2013) 1.03
TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem (2012) 1.02
IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion. J Cereb Blood Flow Metab (2013) 1.02
Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus. J Neuroinflammation (2012) 1.00
Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Curr Med Chem (2014) 0.99
Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res (2013) 0.97
Anxiety after cardiac arrest/cardiopulmonary resuscitation: exacerbated by stress and prevented by minocycline. Stroke (2009) 0.97
Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats. PLoS One (2014) 0.96
Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab (2010) 0.92
Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood-brain barrier disruption. J Neuroinflammation (2014) 0.91
A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats. Am J Pathol (2011) 0.91
Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction. Chin Med (2010) 0.90
The two sides of cytokine signaling and glaucomatous optic neuropathy. J Ocul Biol Dis Infor (2009) 0.88
Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells. Cerebrovasc Dis (2010) 0.88
Transcriptional adaptations following exercise in thoroughbred horse skeletal muscle highlights molecular mechanisms that lead to muscle hypertrophy. BMC Genomics (2009) 0.88
Nerves and neovessels inhibit each other in the cornea. Invest Ophthalmol Vis Sci (2013) 0.88
NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. J Neuroinflammation (2009) 0.87
Neurovascular protection by targeting early blood-brain barrier disruption with neurotrophic factors after ischemia-reperfusion in rats*. J Cereb Blood Flow Metab (2013) 0.85
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients. Diabetes Care (2013) 0.85
NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species. Int J Biol Sci (2015) 0.85
ROCKs as immunomodulators of stroke. Expert Opin Ther Targets (2012) 0.84
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. Korean J Physiol Pharmacol (2011) 0.84
Erratum: The two sides of cytokine signaling and glaucomatous optic neuropathy. J Ocul Biol Dis Infor (2009) 0.83
Antioxidant and anti-excitotoxicity effect of Gualou Guizhi decoction on cerebral ischemia/reperfusion injury in rats. Exp Ther Med (2015) 0.83
Effects of acupuncture at GV20 and ST36 on the expression of matrix metalloproteinase 2, aquaporin 4, and aquaporin 9 in rats subjected to cerebral ischemia/reperfusion injury. PLoS One (2014) 0.83
Ameliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemic-reperfusion injury. Mol Med Rep (2015) 0.82
Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury. J Neuroinflammation (2011) 0.82
Platelet-neutrophil interactions under thromboinflammatory conditions. Cell Mol Life Sci (2015) 0.82
The importance of molecular histology to study glial influence on neurodegenerative disorders. Focus on recent developed single cell laser microdissection. J Mol Histol (2009) 0.82
Mild hypothermia causes differential, time-dependent changes in cytokine expression and gliosis following endothelin-1-induced transient focal cerebral ischemia. J Neuroinflammation (2011) 0.82
Short-term preoperative dietary restriction is neuroprotective in a rat focal stroke model. PLoS One (2014) 0.82
Multimodality monitoring, inflammation, and neuroregeneration in subarachnoid hemorrhage. Neurosurgery (2014) 0.81
Xanthotoxol exerts neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia. Cell Mol Neurobiol (2013) 0.81
Block of P2X7 receptors could partly reverse the delayed neuronal death in area CA1 of the hippocampus after transient global cerebral ischemia. Purinergic Signal (2013) 0.80
7,8-dihydroxyflavone, a small-molecule tropomyosin-related kinase B (TrkB) agonist, attenuates cerebral ischemia and reperfusion injury in rats. J Mol Histol (2013) 0.80
The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics (2014) 0.79
Nanobodies as modulators of inflammation: potential applications for acute brain injury. Front Cell Neurosci (2014) 0.79
MCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS. Acta Neuropathol Commun (2013) 0.79
Vulnerability to stroke: implications of perinatal programming of the hypothalamic-pituitary-adrenal axis. Front Behav Neurosci (2009) 0.79
Inflammatory mechanisms involved in brain injury following cardiac arrest and cardiopulmonary resuscitation. Biomed Rep (2016) 0.78
Chronological changes in inflammatory cytokines immunoreactivities in the mouse hippocampus after systemic administration of high dosage of tetanus toxin. Exp Brain Res (2012) 0.78
Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke. CNS Neurosci Ther (2014) 0.78
Additional antiepileptic mechanisms of levetiracetam in lithium-pilocarpine treated rats. PLoS One (2013) 0.78
Insulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats. Endocrinology (2015) 0.78
Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats. Biomed Res Int (2015) 0.78
Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia. Exp Ther Med (2015) 0.78
Cerebral ischemic damage in diabetes: an inflammatory perspective. J Neuroinflammation (2017) 0.78
Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury. Sci Rep (2016) 0.78
Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke. Ann Clin Transl Neurol (2017) 0.77
Excitotoxic insults lead to peroxiredoxin hyperoxidation. Oxid Med Cell Longev (2010) 0.77
Fundamental research progress of mild hypothermia in cerebral protection. Springerplus (2013) 0.77
Hypoxic Preconditioning Suppresses Glial Activation and Neuroinflammation in Neonatal Brain Insults. Mediators Inflamm (2015) 0.77
Pathogenic mechanisms following ischemic stroke. Neurol Sci (2017) 0.76
Human umbilical cord blood stem cells: rational for use as a neuroprotectant in ischemic brain disease. Int J Mol Sci (2010) 0.76
Neuroprotective Mechanisms of Taurine against Ischemic Stroke. Brain Sci (2013) 0.76
Propofol Suppressed Hypoxia/Reoxygenation-Induced Apoptosis in HBVSMC by Regulation of the Expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNK. Oxid Med Cell Longev (2016) 0.76
Pro-inflammatory mediators and apoptosis correlate to rt-PA response in a novel mouse model of thromboembolic stroke. PLoS One (2014) 0.76
A method to immunolabel rodent spinal cord neurons and glia for molecular study in specific laser microdissected cells involved in neurodegenerative disorders. J Mol Histol (2009) 0.76
Retinal stem cells transplantation combined with copolymer-1 immunization reduces interferon-gamma levels in an experimental model of glaucoma. Int J Ophthalmol (2011) 0.76
Barrier mechanisms in neonatal stroke. Front Neurosci (2014) 0.76
Risk of Stroke in Patients With Spontaneous Pneumothorax: A Nationwide, Population-Based Study. Medicine (Baltimore) (2016) 0.75
Cellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion Injury. Front Immunol (2016) 0.75
The Neuroprotective Effect of Glycyrrhizic Acid on an Experimental Model of Focal Cerebral Ischemia in Rats. Inflammation (2015) 0.75
Macrophage depletion reduced brain injury following middle cerebral artery occlusion in mice. J Neuroinflammation (2016) 0.75
A protease-activated receptor 1 antagonist protects against global cerebral ischemia/reperfusion injury after asphyxial cardiac arrest in rabbits. Neural Regen Res (2017) 0.75
Molecular and Cellular Responses to Interleukin-4 Treatment in a Rat Model of Transient Ischemia. J Neuropathol Exp Neurol (2016) 0.75
Effect of the PGD2-DP signaling pathway on primary cultured rat hippocampal neuron injury caused by aluminum overload. Sci Rep (2016) 0.75
Hypertonic saline attenuates expression of Notch signaling and proinflammatory mediators in activated microglia in experimentally induced cerebral ischemia and hypoxic BV-2 microglia. BMC Neurosci (2017) 0.75
Intranasal Administration of Interleukin-1 Receptor Antagonist in a Transient Focal Cerebral Ischemia Rat Model. Biomol Ther (Seoul) (2017) 0.75
Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability. Theranostics (2017) 0.75
Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain. PLoS One (2016) 0.75
Microglia and Monocyte-Derived Macrophages in Stroke. Neurotherapeutics (2016) 0.75
Dual anti-ischemic effects of rosmarinic acid n-butyl ester via alleviation of DAPK-p53-mediated neuronal damage and microglial inflammation. Acta Pharmacol Sin (2017) 0.75
MORIN MITIGATES OXIDATIVE STRESS, APOPTOSIS AND INFLAMMATION IN CEREBRAL ISCHEMIC RATS. Afr J Tradit Complement Altern Med (2017) 0.75
Biliverdin administration ameliorates cerebral ischemia reperfusion injury in rats and is associated with proinflammatory factor downregulation. Exp Ther Med (2017) 0.75
PET imaging of the neurovascular interface in cerebrovascular disease. Nat Rev Neurol (2017) 0.75
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents. J Stroke (2017) 0.75
Sesamol attenuates oxidative stress, apoptosis and inflammation in focal cerebral ischemia/reperfusion injury. Exp Ther Med (2017) 0.75
Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis. Arterioscler Thromb Vasc Biol (2017) 0.75
Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats. Mol Genet Genomics (2017) 0.75
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood (2007) 6.03
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron (2005) 3.30
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci (2003) 3.25
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci (2008) 2.87
Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey. Cephalalgia (2012) 2.48
An isochore map of human chromosomes. Genome Res (2006) 2.36
Spontaneous intracranial hypotension syndrome: report of twelve cases. Headache (2004) 2.26
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol (2008) 1.96
Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci U S A (2004) 1.79
Cytosine methylation and CpG, TpG (CpA) and TpA frequencies. Gene (2004) 1.78
Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain (2011) 1.75
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci (2003) 1.66
Genomic GC level, optimal growth temperature, and genome size in prokaryotes. Biochem Biophys Res Commun (2006) 1.61
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci (2009) 1.59
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease. Eur J Neurosci (2009) 1.59
Interleukin-1β causes anxiety by interacting with the endocannabinoid system. J Neurosci (2012) 1.55
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J Leukoc Biol (2003) 1.55
TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol (2012) 1.55
Diagnostic delay and suboptimal management in a referral population with hemicrania continua. Headache (2009) 1.54
Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease. PLoS One (2013) 1.50
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biol Psychiatry (2007) 1.48
Correlations between genomic GC levels and optimal growth temperatures in prokaryotes. FEBS Lett (2004) 1.48
SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain (2010) 1.45
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. Eur J Neurosci (2011) 1.45
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci (2003) 1.41
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci (2002) 1.40
From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res (2005) 1.40
The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? Trends Pharmacol Sci (2003) 1.39
The evolution of isochore patterns in vertebrate genomes. BMC Genomics (2009) 1.38
Dopamine excites fast-spiking interneurons in the striatum. J Neurophysiol (2002) 1.36
Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One (2010) 1.36
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain (2009) 1.35
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci (2006) 1.34
Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Invest (2012) 1.32
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci (2003) 1.31
Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci (2009) 1.27
FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood (2004) 1.27
Localization of the gene-richest and the gene-poorest isochores in the interphase nuclei of mammals and birds. Gene (2002) 1.27
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol (2003) 1.26
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Mov Disord (2005) 1.26
The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci (2007) 1.23
Identification and enrichment of spermatogonial stem cells displaying side-population phenotype in immature mouse testis. FASEB J (2003) 1.22
Replication timing, chromosomal bands, and isochores. Proc Natl Acad Sci U S A (2008) 1.22
Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology (2005) 1.22
Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord (2005) 1.20
Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Ann Neurol (2011) 1.19
Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons. Eur J Neurosci (2003) 1.19
Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. J Pain (2009) 1.18
Representing GC variation along eukaryotic chromosomes. Gene (2004) 1.18
The new genes of rice: a closer look. Trends Plant Sci (2004) 1.17
P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab (2006) 1.16
Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain (2013) 1.16
REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Mov Disord (2008) 1.15
Voltage-dependent membrane potential oscillations of rat striatal fast-spiking interneurons. J Physiol (2003) 1.15
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Prog Neurobiol (2004) 1.15
Diagnostic and therapeutic errors in cluster headache: a hospital-based study. J Headache Pain (2014) 1.14
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology (2010) 1.14
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology (2006) 1.14
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci (2005) 1.13
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology (2004) 1.13
Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology (2002) 1.13
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. J Neurosci (2004) 1.13
Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiol Dis (2009) 1.12
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics (2006) 1.11
Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease. PLoS One (2010) 1.11
Early and long-term outcome of rehabilitation in stroke patients: the role of patient characteristics, time of initiation, and duration of interventions. Arch Phys Med Rehabil (2003) 1.11
Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology (2005) 1.10
Italian guidelines for primary headaches: 2012 revised version. J Headache Pain (2012) 1.10
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology (2002) 1.10
Synaptic plasticity in the ischaemic brain. Lancet Neurol (2003) 1.09
Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology (2007) 1.09
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2008) 1.09
TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci (2008) 1.08
Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain (2004) 1.08
Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Invest Ophthalmol Vis Sci (2007) 1.07
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci (2004) 1.06
17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res (2008) 1.06
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev Neurosci (2003) 1.06
Late-onset CMT2 associated with a novel missense mutation in the cytoplasmic domain of the MPZ gene. Clin Neurol Neurosurg (2010) 1.06
Isochore pattern and gene distribution in the chicken genome. Gene (2007) 1.06
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol (2012) 1.05
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant (2009) 1.05
Characterization of human Enah gene. Biochim Biophys Acta (2006) 1.05
Isochore patterns and gene distributions in fish genomes. Genomics (2007) 1.04
Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration. J Neurochem (2006) 1.04
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Mult Scler (2010) 1.04
The short-sequence designs of isochores from the human genome. Proc Natl Acad Sci U S A (2008) 1.03
A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain (2009) 1.03
Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of transient receptor potential channels. J Neurophysiol (2005) 1.03
REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord (2006) 1.03
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci (2008) 1.02
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain Behav Immun (2010) 1.02
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. Eur J Neurosci (2002) 1.02
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics (2002) 1.02
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis. Neurol Sci (2009) 1.02
p73-alpha is capable of inducing scotin and ER stress. Oncogene (2004) 1.02
Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res (2009) 1.02
Mapping DNase-I hypersensitive sites on human isochores. Gene (2008) 1.01